These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31819339)

  • 1. LEFT VENTRICULAR LEAD PLACEMENT FOR PACING AND SENSING IN A PATIENT WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY UNDERGOING ICD IMPLANTATION.
    Taleski J; Manola Š; Radeljić V; Bulj N; Delić Brkljačić D; Pavlović N
    Acta Clin Croat; 2019 Jun; 58(2):391-393. PubMed ID: 31819339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular sensing and pacing for sensing difficulties in internal cardioverter defibrillator therapy for arrhythmogenic right ventricular cardiomyopathy.
    Lochy S; François B; Hollanders G; Provenier F
    Europace; 2010 Aug; 12(8):1195-6. PubMed ID: 20348554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term right ventricular implantable cardioverter-defibrillator lead performance in arrhythmogenic right ventricular cardiomyopathy.
    Herman AR; Gardner M; Steinberg C; Yeung-Lai-Wah JA; Healey JS; Leong-Sit P; Krahn AD; Chakrabarti S
    Heart Rhythm; 2016 Oct; 13(10):1964-70. PubMed ID: 27321245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Performance of Right Ventricular Implantable Cardioverter-Defibrillator Leads in Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy.
    Sagawa Y; Nagata Y; Yamaguchi T; Mitsui K; Nagamine T; Yamaguchi J; Hijikata S; Watanabe K; Masuda R; Miyazaki R; Kaneko M; Miwa N; Sekigawa M; Hara N; Nozato T; Ashikaga T; Goya M; Sasano T; Hirao K
    Int Heart J; 2020 Jan; 61(1):39-45. PubMed ID: 31956141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular cardiomyopathy: the course of electronic parameters, clinical features, and complications during long-term follow-up.
    Mugnai G; Tomei R; Dugo C; Tomasi L; Morani G; Vassanelli C
    J Interv Card Electrophysiol; 2014 Oct; 41(1):23-9. PubMed ID: 24928487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional left ventricular septal lead facilitates R-wave sensing of implantable cardioverter-defibrillator in arrhythmogenic right ventricular cardiomyopathy: a case report.
    Lu W; Chen K; Dai Y; Zhang S
    Eur Heart J Case Rep; 2023 Jan; 7(1):ytac491. PubMed ID: 36685095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The right ventricular outflow tract as an unusual location for an implantable defibrillator electrode in a patient with arrhythmogenic right ventricular dysplasia.
    Matsuo K; Kurita T; Eguchi M; Nakao K; Komiya N; Kawano H; Isomoto S; Toda G; Hayano M; Yano K
    Jpn Circ J; 2001 Nov; 65(11):994-6. PubMed ID: 11716254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular pacing in right ventricular cardiomyopathy: blessing or blunder?
    Niazi I; Rennick N; Kiemen JA; Sra J
    Pacing Clin Electrophysiol; 2013 Mar; 36(3):e64-6. PubMed ID: 21895726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
    Schinkel AF
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience.
    Orgeron GM; Bhonsale A; Migliore F; James CA; Tichnell C; Murray B; Bertaglia E; Cadrin-Tourigny J; De Franceschi P; Crosson J; Tandri H; Corrado D; Calkins H
    J Am Heart Assoc; 2018 Nov; 7(21):e008782. PubMed ID: 30608223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
    Woźniak O; Borowiec K; Konka M; Cicha-Mikołajczyk A; Przybylski A; Szumowski Ł; Hoffman P; Poślednik K; Biernacka EK
    Heart; 2022 Jan; 108(1):22-28. PubMed ID: 33674353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator lead placement in the middle cardiac vein after tricuspid valve surgery.
    Lopez JA
    Europace; 2012 Jun; 14(6):853-8. PubMed ID: 22333241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in amplitude of intracardiac ventricular electrogram and inappropriate therapy in patients with an implantable cardioverter defibrillator.
    Watanabe H; Chinushi M; Izumi D; Sato A; Okada S; Okamura K; Komura S; Hosaka Y; Furushima H; Washizuka T; Aizawa Y
    Int Heart J; 2006 May; 47(3):363-70. PubMed ID: 16823242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
    J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy.
    Boriani G; Artale P; Biffi M; Martignani C; Frabetti L; Valzania C; Diemberger I; Ziacchi M; Bertini M; Rapezzi C; Parlapiano M; Branzi A
    Heart Vessels; 2007 May; 22(3):184-92. PubMed ID: 17533523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
    Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registry.
    Migliore F; Viani S; Bongiorni MG; Zorzi A; Silvetti MS; Francia P; D'Onofrio A; De Franceschi P; Sala S; Donzelli S; Ricciardi G; Menardi E; Giammaria M; La Greca C; Bauce B; Rigato I; Iliceto S; Bertaglia E; Diemberger I; Corrado D
    Int J Cardiol; 2019 Apr; 280():74-79. PubMed ID: 30661851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators.
    Link MS; Wang PJ; Haugh CJ; Homoud MK; Foote CB; Costeas XB; Estes NA
    J Interv Card Electrophysiol; 1997 Feb; 1(1):41-8. PubMed ID: 9869950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parameters of cardiac pacing and effectiveness of defibrillation during implantable cardioverter-defibrillator lead implantation to right ventricle outflow tract].
    Rydlewska A; Machejek J; Engel A; Lelakowski J
    Pol Merkur Lekarski; 2013 Nov; 35(209):254-8. PubMed ID: 24575643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.